Zydus Cadila Launches Nudoxa Chemotherapy For Treating Aggressive Cancer
This article was originally published in PharmAsia News
Executive Summary
Zydus Cadila announced it has launched its Nudoxa (doxorubiein) drug for treating cancer, using a new type of drug-delivery system. The drug is a variant of the liposomal doxorubiein drug that offers cancer therapy against aggressive and malignant tumors without the accompanying side effects. The drug is made by Zydus-BSV Pharma, a joint venture of Zydus Cadila and Bharat Serums and Vaccines, and is used as a chemotherapy for treating various cancers, primarily breast cancer. (Click here for more